Updated April 2026 · 14-minute read · Sources: NHS, NICE, RCN, WHO, HCPC
A Clinical Management Plan (CMP) is a written, patient-specific agreement between an independent prescriber (usually a doctor or dentist) and a supplementary prescriber. It legally defines the conditions to be treated, the medicines that can be prescribed, and the limits of each clinician's responsibility — all with the patient's informed consent.
If you've ever wondered how a nurse, pharmacist, or physiotherapist can legally prescribe medicines that were traditionally a doctor's job — the CMP is the answer. It's not just a form. It's a structured safety net. It defines who does what, when to escalate, and what the patient agreed to. Without it, supplementary prescribing simply cannot happen.
This guide walks through every key element of a Clinical Management Plan: its legal basis, required components, real-world use, and why getting it right matters more than most professionals realise.
What Exactly Is a Clinical Management Plan?
According to the Health and Care Professions Council (HCPC), a CMP is "a written plan agreed between a doctor or dentist and a supplementary prescriber for the treatment of a named service user, with the knowledge and agreement of the service user and/or carer." It outlines:
- The illnesses or conditions the supplementary prescriber may treat
- The types of medicines they are permitted to prescribe
- Any limits on the strength or dose of those medicines
Source: HCPC Standards for Prescribing, 2022 — hcpc-uk.org
The Royal College of Nursing (RCN) defines supplementary prescribing as "a voluntary partnership between an Independent Prescriber and a supplementary prescriber to implement an agreed patient-specific Clinical Management Plan with the patient's agreement." That word — voluntary — is important. No one can be forced into this arrangement. It works because everyone at the table agrees.
Source: RCN Non-Medical Prescribing Advice Guide — rcn.org.uk
Who Needs a Clinical Management Plan?
CMPs are specifically for supplementary prescribers. These are regulated healthcare professionals who have completed approved post-registration prescribing training. Under the Human Medicines Regulations 2012, they may prescribe any medicine within their clinical competence — but only within the scope defined by an agreed CMP.
Professions currently eligible to train as supplementary prescribers (per the HCPC) include:
- Nurses and midwives (regulated by the NMC)
- Pharmacists
- Physiotherapists
- Podiatrists / chiropodists
- Radiographers (therapeutic)
- Dietitians
- Paramedics
- Optometrists
Source: HCPC Standards for Prescribing; SPS NHS — sps.nhs.uk
Source: WHO Global Patient Safety Report 2024 — who.int
Core Components of a Clinical Management Plan
A CMP is not a vague treatment summary. It has defined, mandatory elements. According to NHS guidance and the Birmingham and Solihull Mental Health NHS Foundation Trust Non-Medical Prescribing Policy (updated April 2024), the CMP must include all of the following:
| CMP Component | What It Must Include | Why It Matters |
|---|---|---|
| Patient Details | Full name, date of birth, NHS number, address | Ensures plan is patient-specific, not generic |
| Condition(s) to be Managed | Named diagnoses or clinical conditions covered | Sets the legal boundary of the SP's authority |
| Medicines Authorised | Named medicines, doses, frequencies, formulations | Prevents unauthorised prescribing outside agreed scope |
| Allergies & Sensitivities | Known drug allergies and adverse reactions | Critical patient safety safeguard |
| Monitoring Parameters | Blood tests, clinical reviews, response targets | Tracks effectiveness and flags harm early |
| Escalation Criteria | When the SP must refer back to the IP | Maintains safety; prevents clinical overreach |
| Review Date | Formal joint review — typically within 12 months maximum | Ensures plan stays current and clinically valid |
| Signatures | Independent prescriber, supplementary prescriber, patient | Legal validity of the agreement |
Source: Birmingham & Solihull Mental Health NHS FT Non-Medical Prescribing Policy, April 2024 — bsmhft.nhs.uk
The Legal Framework Behind CMPs
CMPs don't just exist because someone thought they were a good idea. They have a firm statutory foundation. Here's the regulatory chain that makes them both necessary and enforceable:
- Human Medicines Regulations 2012 — defines supplementary prescribers and their legal prescribing powers
- Medicines Act 1968 — the original legislative basis for who may supply or administer medicines
- NMC Code (for nurses/midwives) — requires prescribing within competence and within agreed CMP boundaries
- HCPC Standards for Prescribing (2022) — applies to all other HCPC-regulated supplementary prescribers
- NICE Clinical Guidelines — CMPs may reference NICE guidance to identify appropriate medicines and dose parameters
The NHS Specialist Pharmacy Service notes that "supplementary prescribers are non-medical prescribers who can prescribe medicines within their clinical competence according to a clinical management plan (CMP), written and agreed with" the independent prescriber. That phrase "written and agreed" is key — a verbal agreement simply does not count.
Source: NHS Specialist Pharmacy Service — sps.nhs.uk
How to Write a Clinical Management Plan: Step-by-Step
Either the independent prescriber or the supplementary prescriber can draft the CMP. But both must formally agree before prescribing begins. Here's how a well-structured CMP comes together:
Confirm the Patient is Suitable
The independent prescriber assesses whether the patient's condition is stable and appropriate for supplementary management. The patient must also give informed consent to sharing their full medical record with the SP.
Define the Scope Together
Both prescribers agree on which conditions are covered, which medicines may be used, and what the SP's specific limits are. The plan should be "as simple as possible" and may reference NICE or local evidence-based guidelines.
Document Everything Clearly
Write the CMP in plain, unambiguous language. Vague terms like "adjust dose as needed" are not enough — specify ranges, triggers, and hard ceilings. Put it in the patient record.
Get All Three Signatures
The IP signs, the SP signs, and the patient (or their carer) signs. All three signatures confirm the voluntary, informed nature of the prescribing partnership.
Set a Review Date
Schedule a formal joint clinical review — usually within 12 months. For stable, long-term conditions this may occasionally extend beyond 12 months, but that decision rests with the independent prescriber and must be documented.
Source: NHS Scotland Supplementary Prescribing Implementation Guide; BSMHFT Non-Medical Prescribing Policy 2024
What Conditions Can a CMP Cover?
In principle, a CMP can cover any diagnosed condition. There is no legally restricted list. In practice, CMPs are most commonly used for the management of:
| Clinical Area | Common CMP Use Cases |
|---|---|
| Long-term Conditions | Type 2 diabetes, hypertension, COPD, asthma, heart failure |
| Mental Health | Schizophrenia maintenance, depression, anxiety management |
| Pain Management | Chronic pain, post-surgical analgesia, palliative care |
| Dermatology | Eczema, psoriasis, wound management |
| Nutrition & Dietetics | Parenteral nutrition protocols, micronutrient supplementation |
| Oncology | Supportive medicines during chemotherapy cycles |
CMP vs Independent Prescribing: Key Differences
| Feature | Clinical Management Plan (CMP) | Independent Prescribing |
|---|---|---|
| Who uses it | Supplementary prescribers (SP) | Independent prescribers (IP) |
| Requires doctor involvement | Yes — doctor or dentist must agree the plan | No — prescribes autonomously |
| Scope of prescribing | Limited to medicines named in the CMP | Any medicine within clinical competence |
| Diagnosis requirement | Diagnosis must already be established by the IP | IP can diagnose and prescribe in same encounter |
| Patient consent | Explicit consent to the CMP required | Standard informed consent to treatment |
| Controlled drugs | Only if named in CMP | Within scope of practice and legislation |
Common CMP Mistakes That Create Legal Risk
Most CMP errors are not caused by malice — they're caused by rushing. Here are the most common problems seen in NHS trust audits and prescribing reviews:
- No patient signature — makes the CMP legally void; prescribing after this point is unlawful
- Vague dose ranges — terms like "appropriate dose" leave the SP exposed with no clear ceiling
- Missing review date — plans without a review date can drift on indefinitely, even when the patient's condition changes
- Using a CMP from another patient — CMPs are patient-specific by law; a generic or template version is not valid on its own
- SP prescribing outside named conditions — this exceeds legal authority, even if clinically sensible
- IP and SP not communicating — regulations require ongoing communication between prescribers, not just an initial agreement
- No escalation pathway documented — if something goes wrong, who does the SP call? This must be written in the plan
The Rotherham Doncaster and South Humber NHS Foundation Trust's Non-Medical Prescribing Policy makes clear that "supplementary prescribers must only prescribe within their clinical field of competence" and that the prescribing arrangement depends on continuous communication, not a one-off document.
Source: RDaSH NHS Foundation Trust Non-Medical Prescribing Policy — rdash.nhs.uk
CMPs and Patient Safety: Why the Structure Saves Lives
Structured clinical planning is not bureaucratic box-ticking. It is a demonstrably effective patient safety tool. The WHO's Global Patient Safety Report 2024 found that more than one in ten patients experience harm in medical care settings — and roughly half of that harm is preventable.
Well-designed CMPs directly address multiple causes of preventable medication harm:
- Medication errors — clearly documented drug names, doses, and limits prevent wrong prescribing
- Communication failures — the three-party agreement ensures the patient, IP, and SP all share the same understanding
- Scope creep — explicit condition and medicine boundaries stop clinicians drifting into areas beyond their expertise
- Monitoring gaps — built-in review dates ensure patients are not lost to follow-up
Source: WHO Global Patient Safety Report 2024 — who.int
The same report notes that progress on patient safety implementation has been tracked across 108 countries — and that structured care protocols are a cornerstone of improvement efforts globally.
How NICE Guidelines Fit Into a CMP
A CMP does not have to reinvent clinical medicine from scratch. NHS policy explicitly allows — and encourages — CMPs to reference NICE guidelines and local formularies to define prescribing parameters. This is actually smart design: rather than writing lengthy bespoke drug protocols into every CMP, the SP and IP can simply agree that prescribing follows, for example, NICE guidance CG87 (Type 2 diabetes) or a local trust formulary.
NICE clinical guidelines are, in the organisation's own words, "recommendations on how healthcare and other professionals should care for people with specific conditions, based on the best available evidence." They are developed using internationally recognised methodology — specifically the GRADE system for grading evidence quality — and are considered the benchmark for NHS clinical standards.
Source: NICE Guidelines — nice.org.uk
Using NICE references in a CMP also adds auditability. If a prescribing decision is ever questioned, the SP can demonstrate they acted within an evidence-based, nationally recognised framework.
Reviewing and Updating a CMP
A CMP is a living document. It should change when the patient's situation changes. According to NHS supplementary prescribing guidance, the review process works like this:
- Ongoing communication: The IP and SP must maintain ad-hoc communication while the SP is actively prescribing
- Formal joint review: Must occur at agreed intervals — generally within a maximum of 12 months
- Longer intervals permitted: In stable, long-term conditions, the IP may agree to extend beyond 12 months — but this must be explicitly documented in the CMP
- Change of IP: If the patient's responsible doctor changes, the CMP cannot simply continue — the SP must negotiate a new prescribing partnership agreement with the new IP
- Patient condition changes: Any significant change in diagnosis, medication, or patient circumstances requires immediate CMP review or suspension of supplementary prescribing
Source: Supplementary Prescribing by Nurses, Pharmacists, Chiropodists/Podiatrists — DHSC UK Government Guidance
Frequently Asked Questions
Can a CMP cover more than one condition?
Yes. A CMP can cover multiple related or unrelated conditions, provided each is clearly named in the plan and the SP has the clinical competence to manage all of them. Many long-term condition CMPs bundle comorbidities — for example, hypertension, hyperlipidaemia, and type 2 diabetes in the same patient.
Does the patient have to sign the CMP?
Yes — patient consent and awareness is a legal requirement of a valid CMP. The patient must know who their supplementary prescriber is, what medicines may be prescribed, and what the plan covers. If a patient does not consent to sharing their full medical record with the SP, they are not suitable for a supplementary prescribing arrangement.
Can a CMP be held electronically?
Yes. NHS guidance allows CMPs to be held as either written or electronic documents, provided the electronic record is part of the patient's official medical record and both prescribers have access. Electronic CMPs are increasingly common within integrated care settings.
What happens if an SP prescribes outside the CMP?
Prescribing outside the CMP is unlawful. It can result in professional regulatory action by the NMC or HCPC, employer disciplinary proceedings, potential criminal liability under the Medicines Act, and — most importantly — direct patient harm. There is no grey area here. The CMP boundary is the legal boundary.
Who is responsible if something goes wrong under a CMP?
Both the independent prescriber and the supplementary prescriber carry professional responsibility within their respective roles. The SP is accountable for their own prescribing decisions within the CMP; the IP is accountable for the overall treatment plan and for ensuring the CMP is appropriate. Shared responsibility does not mean diluted responsibility — both remain professionally and legally accountable.
Key Takeaways
- A CMP is the legal foundation of all supplementary prescribing in the UK — no CMP means no authority to prescribe
- It must be patient-specific, written, and signed by the independent prescriber, supplementary prescriber, and the patient
- The CMP must include: named conditions, authorised medicines and doses, monitoring requirements, escalation criteria, and a review date
- CMPs may reference NICE guidelines and local formularies rather than spelling out every clinical protocol from scratch
- Controlled drugs can be prescribed under a CMP — but only if explicitly named in the plan
- A formal joint clinical review is required at least every 12 months, or sooner if the patient's condition changes
- Getting CMPs right is a direct patient safety intervention — structured prescribing protocols reduce preventable medication harm
Sources & References
- Health and Care Professions Council. Standards for Prescribing. 2022. hcpc-uk.org
- Royal College of Nursing. Non-Medical Prescribing Advice Guide. Updated February 2026. rcn.org.uk
- NHS Specialist Pharmacy Service. Legal Mechanisms to Supply and Administer Medicines. 2024. sps.nhs.uk
- Birmingham and Solihull Mental Health NHS Foundation Trust. Non-Medical Prescribing Policy. April 2024. bsmhft.nhs.uk
- Rotherham Doncaster and South Humber NHS Foundation Trust. Non-Medical Prescribing Policy. 2024. rdash.nhs.uk
- National Institute for Health and Care Excellence. How NICE Clinical Guidelines Are Developed. nice.org.uk
- World Health Organization. Global Patient Safety Report 2024. ISBN 9789240095458. who.int
- Oxford University Press / Oxford Academic. Oxford Handbook of Prescribing for Nurses and Allied Health Professionals — Clinical Management Plans. academic.oup.com
- NHS Scotland / Scottish Government. A Guide for Implementation: Supplementary Prescribing by Nurses within NHSScotland. 2003. gov.scot
Updated April 2026 · 14-minute read · Sources: NHS, NICE, RCN, WHO, HCPC
A Clinical Management Plan (CMP) is a written, patient-specific agreement between an independent prescriber (usually a doctor or dentist) and a supplementary prescriber. It legally defines the conditions to be treated, the medicines that can be prescribed, and the limits of each clinician's responsibility — all with the patient's informed consent.
If you've ever wondered how a nurse, pharmacist, or physiotherapist can legally prescribe medicines that were traditionally a doctor's job — the CMP is the answer. It's not just a form. It's a structured safety net. It defines who does what, when to escalate, and what the patient agreed to. Without it, supplementary prescribing simply cannot happen.
This guide walks through every key element of a Clinical Management Plan: its legal basis, required components, real-world use, and why getting it right matters more than most professionals realise.
What Exactly Is a Clinical Management Plan?
According to the Health and Care Professions Council (HCPC), a CMP is "a written plan agreed between a doctor or dentist and a supplementary prescriber for the treatment of a named service user, with the knowledge and agreement of the service user and/or carer." It outlines:
- The illnesses or conditions the supplementary prescriber may treat
- The types of medicines they are permitted to prescribe
- Any limits on the strength or dose of those medicines
Source: HCPC Standards for Prescribing, 2022 — hcpc-uk.org
The Royal College of Nursing (RCN) defines supplementary prescribing as "a voluntary partnership between an Independent Prescriber and a supplementary prescriber to implement an agreed patient-specific Clinical Management Plan with the patient's agreement." That word — voluntary — is important. No one can be forced into this arrangement. It works because everyone at the table agrees.
Source: RCN Non-Medical Prescribing Advice Guide — rcn.org.uk
Who Needs a Clinical Management Plan?
CMPs are specifically for supplementary prescribers. These are regulated healthcare professionals who have completed approved post-registration prescribing training. Under the Human Medicines Regulations 2012, they may prescribe any medicine within their clinical competence — but only within the scope defined by an agreed CMP.
Professions currently eligible to train as supplementary prescribers (per the HCPC) include:
- Nurses and midwives (regulated by the NMC)
- Pharmacists
- Physiotherapists
- Podiatrists / chiropodists
- Radiographers (therapeutic)
- Dietitians
- Paramedics
- Optometrists
Source: HCPC Standards for Prescribing; SPS NHS — sps.nhs.uk
Source: WHO Global Patient Safety Report 2024 — who.int
Core Components of a Clinical Management Plan
A CMP is not a vague treatment summary. It has defined, mandatory elements. According to NHS guidance and the Birmingham and Solihull Mental Health NHS Foundation Trust Non-Medical Prescribing Policy (updated April 2024), the CMP must include all of the following:
| CMP Component | What It Must Include | Why It Matters |
|---|---|---|
| Patient Details | Full name, date of birth, NHS number, address | Ensures plan is patient-specific, not generic |
| Condition(s) to be Managed | Named diagnoses or clinical conditions covered | Sets the legal boundary of the SP's authority |
| Medicines Authorised | Named medicines, doses, frequencies, formulations | Prevents unauthorised prescribing outside agreed scope |
| Allergies & Sensitivities | Known drug allergies and adverse reactions | Critical patient safety safeguard |
| Monitoring Parameters | Blood tests, clinical reviews, response targets | Tracks effectiveness and flags harm early |
| Escalation Criteria | When the SP must refer back to the IP | Maintains safety; prevents clinical overreach |
| Review Date | Formal joint review — typically within 12 months maximum | Ensures plan stays current and clinically valid |
| Signatures | Independent prescriber, supplementary prescriber, patient | Legal validity of the agreement |
Source: Birmingham & Solihull Mental Health NHS FT Non-Medical Prescribing Policy, April 2024 — bsmhft.nhs.uk
The Legal Framework Behind CMPs
CMPs don't just exist because someone thought they were a good idea. They have a firm statutory foundation. Here's the regulatory chain that makes them both necessary and enforceable:
- Human Medicines Regulations 2012 — defines supplementary prescribers and their legal prescribing powers
- Medicines Act 1968 — the original legislative basis for who may supply or administer medicines
- NMC Code (for nurses/midwives) — requires prescribing within competence and within agreed CMP boundaries
- HCPC Standards for Prescribing (2022) — applies to all other HCPC-regulated supplementary prescribers
- NICE Clinical Guidelines — CMPs may reference NICE guidance to identify appropriate medicines and dose parameters
The NHS Specialist Pharmacy Service notes that "supplementary prescribers are non-medical prescribers who can prescribe medicines within their clinical competence according to a clinical management plan (CMP), written and agreed with" the independent prescriber. That phrase "written and agreed" is key — a verbal agreement simply does not count.
Source: NHS Specialist Pharmacy Service — sps.nhs.uk
How to Write a Clinical Management Plan: Step-by-Step
Either the independent prescriber or the supplementary prescriber can draft the CMP. But both must formally agree before prescribing begins. Here's how a well-structured CMP comes together:
Confirm the Patient is Suitable
The independent prescriber assesses whether the patient's condition is stable and appropriate for supplementary management. The patient must also give informed consent to sharing their full medical record with the SP.
Define the Scope Together
Both prescribers agree on which conditions are covered, which medicines may be used, and what the SP's specific limits are. The plan should be "as simple as possible" and may reference NICE or local evidence-based guidelines.
Document Everything Clearly
Write the CMP in plain, unambiguous language. Vague terms like "adjust dose as needed" are not enough — specify ranges, triggers, and hard ceilings. Put it in the patient record.
Get All Three Signatures
The IP signs, the SP signs, and the patient (or their carer) signs. All three signatures confirm the voluntary, informed nature of the prescribing partnership.
Set a Review Date
Schedule a formal joint clinical review — usually within 12 months. For stable, long-term conditions this may occasionally extend beyond 12 months, but that decision rests with the independent prescriber and must be documented.
Source: NHS Scotland Supplementary Prescribing Implementation Guide; BSMHFT Non-Medical Prescribing Policy 2024
What Conditions Can a CMP Cover?
In principle, a CMP can cover any diagnosed condition. There is no legally restricted list. In practice, CMPs are most commonly used for the management of:
| Clinical Area | Common CMP Use Cases |
|---|---|
| Long-term Conditions | Type 2 diabetes, hypertension, COPD, asthma, heart failure |
| Mental Health | Schizophrenia maintenance, depression, anxiety management |
| Pain Management | Chronic pain, post-surgical analgesia, palliative care |
| Dermatology | Eczema, psoriasis, wound management |
| Nutrition & Dietetics | Parenteral nutrition protocols, micronutrient supplementation |
| Oncology | Supportive medicines during chemotherapy cycles |
CMP vs Independent Prescribing: Key Differences
| Feature | Clinical Management Plan (CMP) | Independent Prescribing |
|---|---|---|
| Who uses it | Supplementary prescribers (SP) | Independent prescribers (IP) |
| Requires doctor involvement | Yes — doctor or dentist must agree the plan | No — prescribes autonomously |
| Scope of prescribing | Limited to medicines named in the CMP | Any medicine within clinical competence |
| Diagnosis requirement | Diagnosis must already be established by the IP | IP can diagnose and prescribe in same encounter |
| Patient consent | Explicit consent to the CMP required | Standard informed consent to treatment |
| Controlled drugs | Only if named in CMP | Within scope of practice and legislation |
Common CMP Mistakes That Create Legal Risk
Most CMP errors are not caused by malice — they're caused by rushing. Here are the most common problems seen in NHS trust audits and prescribing reviews:
- No patient signature — makes the CMP legally void; prescribing after this point is unlawful
- Vague dose ranges — terms like "appropriate dose" leave the SP exposed with no clear ceiling
- Missing review date — plans without a review date can drift on indefinitely, even when the patient's condition changes
- Using a CMP from another patient — CMPs are patient-specific by law; a generic or template version is not valid on its own
- SP prescribing outside named conditions — this exceeds legal authority, even if clinically sensible
- IP and SP not communicating — regulations require ongoing communication between prescribers, not just an initial agreement
- No escalation pathway documented — if something goes wrong, who does the SP call? This must be written in the plan
The Rotherham Doncaster and South Humber NHS Foundation Trust's Non-Medical Prescribing Policy makes clear that "supplementary prescribers must only prescribe within their clinical field of competence" and that the prescribing arrangement depends on continuous communication, not a one-off document.
Source: RDaSH NHS Foundation Trust Non-Medical Prescribing Policy — rdash.nhs.uk
CMPs and Patient Safety: Why the Structure Saves Lives
Structured clinical planning is not bureaucratic box-ticking. It is a demonstrably effective patient safety tool. The WHO's Global Patient Safety Report 2024 found that more than one in ten patients experience harm in medical care settings — and roughly half of that harm is preventable.
Well-designed CMPs directly address multiple causes of preventable medication harm:
- Medication errors — clearly documented drug names, doses, and limits prevent wrong prescribing
- Communication failures — the three-party agreement ensures the patient, IP, and SP all share the same understanding
- Scope creep — explicit condition and medicine boundaries stop clinicians drifting into areas beyond their expertise
- Monitoring gaps — built-in review dates ensure patients are not lost to follow-up
Source: WHO Global Patient Safety Report 2024 — who.int
The same report notes that progress on patient safety implementation has been tracked across 108 countries — and that structured care protocols are a cornerstone of improvement efforts globally.
How NICE Guidelines Fit Into a CMP
A CMP does not have to reinvent clinical medicine from scratch. NHS policy explicitly allows — and encourages — CMPs to reference NICE guidelines and local formularies to define prescribing parameters. This is actually smart design: rather than writing lengthy bespoke drug protocols into every CMP, the SP and IP can simply agree that prescribing follows, for example, NICE guidance CG87 (Type 2 diabetes) or a local trust formulary.
NICE clinical guidelines are, in the organisation's own words, "recommendations on how healthcare and other professionals should care for people with specific conditions, based on the best available evidence." They are developed using internationally recognised methodology — specifically the GRADE system for grading evidence quality — and are considered the benchmark for NHS clinical standards.
Source: NICE Guidelines — nice.org.uk
Using NICE references in a CMP also adds auditability. If a prescribing decision is ever questioned, the SP can demonstrate they acted within an evidence-based, nationally recognised framework.
Reviewing and Updating a CMP
A CMP is a living document. It should change when the patient's situation changes. According to NHS supplementary prescribing guidance, the review process works like this:
- Ongoing communication: The IP and SP must maintain ad-hoc communication while the SP is actively prescribing
- Formal joint review: Must occur at agreed intervals — generally within a maximum of 12 months
- Longer intervals permitted: In stable, long-term conditions, the IP may agree to extend beyond 12 months — but this must be explicitly documented in the CMP
- Change of IP: If the patient's responsible doctor changes, the CMP cannot simply continue — the SP must negotiate a new prescribing partnership agreement with the new IP
- Patient condition changes: Any significant change in diagnosis, medication, or patient circumstances requires immediate CMP review or suspension of supplementary prescribing
Source: Supplementary Prescribing by Nurses, Pharmacists, Chiropodists/Podiatrists — DHSC UK Government Guidance
Frequently Asked Questions
Can a CMP cover more than one condition?
Yes. A CMP can cover multiple related or unrelated conditions, provided each is clearly named in the plan and the SP has the clinical competence to manage all of them. Many long-term condition CMPs bundle comorbidities — for example, hypertension, hyperlipidaemia, and type 2 diabetes in the same patient.
Does the patient have to sign the CMP?
Yes — patient consent and awareness is a legal requirement of a valid CMP. The patient must know who their supplementary prescriber is, what medicines may be prescribed, and what the plan covers. If a patient does not consent to sharing their full medical record with the SP, they are not suitable for a supplementary prescribing arrangement.
Can a CMP be held electronically?
Yes. NHS guidance allows CMPs to be held as either written or electronic documents, provided the electronic record is part of the patient's official medical record and both prescribers have access. Electronic CMPs are increasingly common within integrated care settings.
What happens if an SP prescribes outside the CMP?
Prescribing outside the CMP is unlawful. It can result in professional regulatory action by the NMC or HCPC, employer disciplinary proceedings, potential criminal liability under the Medicines Act, and — most importantly — direct patient harm. There is no grey area here. The CMP boundary is the legal boundary.
Who is responsible if something goes wrong under a CMP?
Both the independent prescriber and the supplementary prescriber carry professional responsibility within their respective roles. The SP is accountable for their own prescribing decisions within the CMP; the IP is accountable for the overall treatment plan and for ensuring the CMP is appropriate. Shared responsibility does not mean diluted responsibility — both remain professionally and legally accountable.
Key Takeaways
- A CMP is the legal foundation of all supplementary prescribing in the UK — no CMP means no authority to prescribe
- It must be patient-specific, written, and signed by the independent prescriber, supplementary prescriber, and the patient
- The CMP must include: named conditions, authorised medicines and doses, monitoring requirements, escalation criteria, and a review date
- CMPs may reference NICE guidelines and local formularies rather than spelling out every clinical protocol from scratch
- Controlled drugs can be prescribed under a CMP — but only if explicitly named in the plan
- A formal joint clinical review is required at least every 12 months, or sooner if the patient's condition changes
- Getting CMPs right is a direct patient safety intervention — structured prescribing protocols reduce preventable medication harm
Sources & References
- Health and Care Professions Council. Standards for Prescribing. 2022. hcpc-uk.org
- Royal College of Nursing. Non-Medical Prescribing Advice Guide. Updated February 2026. rcn.org.uk
- NHS Specialist Pharmacy Service. Legal Mechanisms to Supply and Administer Medicines. 2024. sps.nhs.uk
- Birmingham and Solihull Mental Health NHS Foundation Trust. Non-Medical Prescribing Policy. April 2024. bsmhft.nhs.uk
- Rotherham Doncaster and South Humber NHS Foundation Trust. Non-Medical Prescribing Policy. 2024. rdash.nhs.uk
- National Institute for Health and Care Excellence. How NICE Clinical Guidelines Are Developed. nice.org.uk
- World Health Organization. Global Patient Safety Report 2024. ISBN 9789240095458. who.int
- Oxford University Press / Oxford Academic. Oxford Handbook of Prescribing for Nurses and Allied Health Professionals — Clinical Management Plans. academic.oup.com
- NHS Scotland / Scottish Government. A Guide for Implementation: Supplementary Prescribing by Nurses within NHSScotland. 2003. gov.scot
